You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 8, August 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Leukapheresis for the Treatment of Psoriasis

David M. L. Jupe, BM, Bch; Robert F. Nightingale, MB, BS
Department of Haematology Royal Hobart Hospital Hobart, Tasmania, Australia

Arch Dermatol. 1983;119(8):629-630.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

In recent years, there have been some articles in the literature concerning the treatment of psoriasis by a variety of extracorporeal devices, namely, hemodialysis,1 peritoneal dialysis,2 cardiopulmonary bypass oxygenation,3 and plasmapheresis.4 We describe a similar method of treatment—leukapheresis. Like the other methods, our initial experience was an incidental finding of an unexpected response in a volunteer donor, a man aged 34 years, with psoriasis who was undergoing leukapheresis to provide granulocytes for a relative. His psoriasis, which had been troublesome for more than 20 years, almost disappeared for five months before it gradually returned.

Report of a Case.—

After explaining the procedure and obtaining informed consent, we electively treated a 29-year-old man who had widespread psoriasis, who had been previously treated with the most common modes of treatment, including methotrexate therapy and steroids given for systemic effect. Apart from the extent of the . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.